Drugs / UCB7858
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02879877 | Jul 2016 → Jan 2018 | — | UCB Biopharma S.P.R.L. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UCB7858 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02879877 ↗ |
| Route | Intravenous | “administered by intravenous or subcutaneous infusion” NCT02879877 ↗ |
| Route | Subcutaneous | “administered by intravenous or subcutaneous infusion” NCT02879877 ↗ |